No Data
ST Miao Pharmaceutical (600671.SH): Yuanjia Medical has cumulatively increased its shareholding by 0.2178%.
Gelonghui, November 25丨Special treat Muyao (600671.SH) announced that as of the date of this announcement, the implementation period of the shareholding plan has passed halfway, and Yuanjia Medical has cumulatively increased its shareholding of the company's shares by 265,200 shares, accounting for 0.2178% of the total share capital of the company, with a total increase amounting to 1.6992 million yuan. This shareholding plan has not yet been fully implemented, and Yuanjia Medical will continue to increase its shareholding of the company's shares according to the related shareholding plan within the implementation period.
Hangzhou TianMuShan Pharmaceutical Enterprise Subsidiary Renews Business License
Hangzhou Tianmushan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's (SHSE:600671) 30% Price Boost Is Out Of Tune With Revenues
Tianmushan Pharmaceutical Enterprise Gets Nod to Re-Register Baihe Gujin Oral Liquid
ST Pharmaceutical (600671.SH) has received 17 pharmaceutical re-registration approval notices.
Special treat Vision Pharmaceutical (600671.SH) released an announcement, the company recently received approval and issuance from the Zhejiang Provincial Pharmaceutical Regulatory Agency...
